Compounds > troleandomycin
Page last updated: 2024-09-05

troleandomycin and puromycin

troleandomycin has been researched along with puromycin in 3 studies

Compound Research Comparison

Studies
(troleandomycin)		Trials
(troleandomycin)		Recent Studies (post-2010)
(troleandomycin)		Studies
(puromycin)		Trials
(puromycin)		Recent Studies (post-2010) (puromycin)
56926235,8281311

Protein Interaction Comparison

ProteinTaxonomytroleandomycin (IC50)puromycin (IC50)
30S ribosomal protein S6Escherichia coli K-120.9
30S ribosomal protein S7Escherichia coli K-120.9
50S ribosomal protein L15Escherichia coli K-120.9
50S ribosomal protein L10Escherichia coli K-120.9
50S ribosomal protein L11Escherichia coli K-120.9
50S ribosomal protein L7/L12Escherichia coli K-120.9
50S ribosomal protein L19Escherichia coli K-120.9
50S ribosomal protein L1Escherichia coli K-120.9
50S ribosomal protein L20Escherichia coli K-120.9
50S ribosomal protein L27Escherichia coli K-120.9
50S ribosomal protein L28Escherichia coli K-120.9
50S ribosomal protein L29Escherichia coli K-120.9
50S ribosomal protein L31Escherichia coli K-120.9
50S ribosomal protein L31 type BEscherichia coli K-120.9
50S ribosomal protein L32Escherichia coli K-120.9
50S ribosomal protein L33Escherichia coli K-120.9
50S ribosomal protein L34Escherichia coli K-120.9
50S ribosomal protein L35Escherichia coli K-120.9
50S ribosomal protein L36Escherichia coli K-120.9
30S ribosomal protein S10Escherichia coli K-120.9
30S ribosomal protein S11Escherichia coli K-120.9
30S ribosomal protein S12Escherichia coli K-120.9
30S ribosomal protein S13Escherichia coli K-120.9
30S ribosomal protein S16Escherichia coli K-120.9
30S ribosomal protein S18Escherichia coli K-120.9
30S ribosomal protein S19Escherichia coli K-120.9
30S ribosomal protein S20Escherichia coli K-120.9
30S ribosomal protein S2Escherichia coli K-120.9
30S ribosomal protein S3Escherichia coli K-120.9
30S ribosomal protein S4Escherichia coli K-120.9
30S ribosomal protein S5Escherichia coli K-120.9
30S ribosomal protein S8Escherichia coli K-120.9
30S ribosomal protein S9Escherichia coli K-120.9
50S ribosomal protein L13Escherichia coli K-120.9
50S ribosomal protein L14Escherichia coli K-120.9
50S ribosomal protein L16Escherichia coli K-120.9
50S ribosomal protein L23Escherichia coli K-120.9
30S ribosomal protein S15Escherichia coli K-120.9
50S ribosomal protein L17Escherichia coli K-120.9
50S ribosomal protein L21Escherichia coli K-120.9
50S ribosomal protein L30Escherichia coli K-120.9
50S ribosomal protein L6Escherichia coli K-120.9
30S ribosomal protein S14Escherichia coli K-120.9
30S ribosomal protein S17Escherichia coli K-120.9
30S ribosomal protein S1Escherichia coli K-120.9
50S ribosomal protein L18Escherichia coli K-120.9
Puromycin-sensitive aminopeptidaseHomo sapiens (human)6.075
50S ribosomal protein L2Escherichia coli K-120.9
50S ribosomal protein L3Escherichia coli K-120.9
50S ribosomal protein L24Escherichia coli K-120.9
50S ribosomal protein L4Escherichia coli K-120.9
50S ribosomal protein L22Escherichia coli K-120.9
50S ribosomal protein L5Escherichia coli K-120.9
30S ribosomal protein S21Escherichia coli K-120.9
50S ribosomal protein L25Escherichia coli K-120.9
50S ribosomal protein L36 2Escherichia coli K-120.9

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

3 other study(ies) available for troleandomycin and puromycin

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012